Respiratory

2019 ◽  
pp. 35-60
Author(s):  
Tanya M. Monaghan ◽  
James D. Thomas
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cystic Fibrosis ◽  
Pleural Effusion ◽  
Superior Vena ◽  
Vena Cava ◽  
Cor Pulmonale ◽  
Sleep Apnoea ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Obstructive Sleep

This chapter is about respiratory system, and covers chronic obstructive pulmonary disease, interstitial lung disease, lobectomy, pleural effusion, pneumothorax, tuberculosis, pneumonia, obstructive sleep apnoea, cystic fibrosis, Kartagener’s syndrome, bronchiectasis, superior vena cava obstruction, and cor pulmonale.

Atrial fibrillation and sleep apnoea and chronic obstructive pulmonary disease

ESC CardioMed ◽  
2018 ◽  
pp. 2235-2237
Author(s):  
Tauseef Akhtar ◽  
Jared D. Miller ◽  
Hugh Calkins
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Risk Factor Modification ◽  
Obstructive Sleep ◽  
P Rate

Rate control, rhythm control, and anticoagulation are well entrenched as the three central pillars of atrial fibrillation (AF) management. Risk factor modification of other associated co-morbidities is now emerging as a critical fourth pillar in the prevention and management of AF. Obstructive sleep apnoea and chronic obstructive pulmonary disease, in particular, have important implications in the development of AF and appropriate selection of therapy. This chapter reviews the pathophysiology and clinical evidence linking these conditions with AF. In addition, it discusses important considerations in the management of concurrent AF and obstructive sleep apnoea or chronic obstructive pulmonary disease.

Atrial fibrillation and sleep apnoea and chronic obstructive pulmonary disease

ESC CardioMed ◽  
2018 ◽  
pp. 2235-2237
Author(s):  
Jared D. Miller ◽  
Hugh G. Calkins
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Risk Factor Modification ◽  
Obstructive Sleep ◽  
P Rate

Rate control, rhythm control, and anticoagulation are well entrenched as the three central pillars of atrial fibrillation (AF) management. Risk factor modification of other associated co-morbidities is now emerging as a critical fourth pillar in the prevention and management of AF. Obstructive sleep apnoea and chronic obstructive pulmonary disease, in particular, have important implications in the development of AF and appropriate selection of therapy. This chapter reviews the pathophysiology and clinical evidence linking these conditions with AF. In addition, it discusses important considerations in the management of concurrent AF and obstructive sleep apnoea or chronic obstructive pulmonary disease.

Chest medicine

2017 ◽  
pp. 160-201
Author(s):  
Ian B. Wilkinson ◽  
Tim Raine ◽  
Kate Wiles ◽  
Anna Goodhart ◽  
Catriona Hall ◽  
...  
Keyword(s):  
Respiratory Health ◽  
Cor Pulmonale ◽  
Sleep Apnoea ◽  
Obstructive Sleep Apnoea Syndrome ◽  
Chronic Obstructive ◽  
Allergic Alveolitis ◽  
Obstructive Pulmonary Disease ◽  
Industrial Dust ◽  
Obstructive Sleep ◽  
Bedside Tests

This chapter explores chest medicine, including respiratory health, bedside tests in chest medicine, further investigations in chest medicine, pneumonia, bronchiectasis, cystic fibrosis (CF), lung tumours, fungi and the lung, asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), respiratory failure, pulmonary embolism (PE), pneumothorax, pleural effusion, obstructive sleep apnoea syndrome, cor pulmonale, sarcoidosis, interstitial lung disease (ILD), extrinsic allergic alveolitis (EAA), idiopathic pulmonary fibrosis (IPF), and industrial dust diseases.

Sign in / Sign up

Export Citation Format

Share Document